INSTRUCCIONES OFICIALES

Tirzepatide15 mg

Instrucciones originales de producto.

Modelo
M2
Formato
4 viales
Producto
Tirzepatide
Potencia declarada
15 mg

Esta página reúne la documentación oficial disponible para la presentación identificada. Consulte siempre el nombre, el código y el formato del envase.

El aviso de presentación no modifica este documento original. Verifique que el nombre, código y presentación de la etiqueta física correspondan a esta consulta.

Documento oficialDocumento original · Inglés

Producto

Tirzepatide

Potencia declarada

15 mg

Modelo

M2

Formato

4 viales

Documento técnico en su idioma original. Se conservan la redacción, las cifras y las advertencias de la documentación oficial.

Original product illustration: tirzepatide-vial-15-mg
Referencia visual incluida en el documento original
Contenido original

Metabolic Care M2

Tirzepatide 15 mg 
Vials x4

This product is a ready-to-use sterile injectable solution of tirzepatide supplied in vials intended for single-use per vial. It is intended for institutional and professional use.

Ready-to-use sterile solution
For subcutaneous injection

Institutional use only

Composition and Format

  • Active compound: Tirzepatide

  • Content per vial: 15 mg in 0.5 ml

  • Volume per vial: 0.5 ml

  • Total content: 60 mg

  • Form: Ready-to-use sterile injectable solution

  • Presentation: Single-use vial

  • Route of administration: Subcutaneous injection

  • Packaging: 4 vials (15 mg / 0.5 ml each)

Dosage Information

  • Dose per vial: 15 mg (0.5 ml)

  • Administration: One vial per dose

  • Frequency: Use once per week or as directed by a healthcare professional

Intended Use

This product is intended exclusively for use by licensed institutions and qualified healthcare professionals. It is not intended for direct sale to the public and should be used in accordance with institutional protocols and applicable regulations.

Instructions for Use

Use only with sterile needles and syringes.

Use once per week or as directed.

  1. Withdraw the full content of one vial using a sterile syringe. 

  2. Inject slowly into the subcutaneous tissue (abdomen, thigh, or upper arm).

  3. Dispose of the needle and vial safely after use.

Storage and Handling

  • Store refrigerated at 2–8 °C.

  • Do not freeze.

  • Protect from light.

  • Protect from inappropriate storage conditions.

Safety Information

  • Refer to the leaflet before use.

  • Do not use if the solution is cloudy or contains particles.

  • Do not use if the vial is damaged or compromised.

  • Use only with sterile needles and syringes.

  • Use only as directed by a healthcare professional.

  • Keep out of reach of children.

Regulatory and Disclaimer

This information is provided strictly for institutional and informational purposes only.
True North Labs does not provide medical advice or therapeutic recommendations.
Always follow applicable regulations, institutional protocols, and professional guidance.

Distribution Information

Distributed by: True North Labs

Verifique que el documento corresponda al nombre, código y presentación del etiquetado físico. Esta consulta no es una recomendación médica ni una confirmación de autorizaciones regulatorias.